Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Gaffney

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Rheumatology Advances in Practice|May 17, 2023
Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scopeSizheng Steven Zhao, Stephanie R Harrison, Antoni Chan, et al.
Advances in Therapy|May 8, 2020
Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA StudyUta Kiltz, Petros P Sfikakis, Karl Gaffney, et al.
Annals of the Rheumatic Diseases|January 17, 2023
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trialsDésirée van der Heijde, Atul Deodhar, Xenofon Baraliakos, et al.
Rheumatology (Oxford, England)|April 8, 2025
Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Rheumatology (Oxford, England)|April 8, 2025
The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Nature Communications|May 22, 2015
Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1Adrian Cortes, Sara L Pulit, Paul J Leo, et al.
Nature Genetics|July 12, 2011
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibilityDavid M Evans, Chris C A Spencer, Jennifer J Pointon, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Rheumatology Advances in Practice|May 17, 2023
Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scopeSizheng Steven Zhao, Stephanie R Harrison, Antoni Chan, et al.
Advances in Therapy|May 8, 2020
Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA StudyUta Kiltz, Petros P Sfikakis, Karl Gaffney, et al.
Annals of the Rheumatic Diseases|January 17, 2023
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trialsDésirée van der Heijde, Atul Deodhar, Xenofon Baraliakos, et al.
Rheumatology (Oxford, England)|April 8, 2025
Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Rheumatology (Oxford, England)|April 8, 2025
The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Nature Communications|May 22, 2015
Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1Adrian Cortes, Sara L Pulit, Paul J Leo, et al.
Nature Genetics|July 12, 2011
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibilityDavid M Evans, Chris C A Spencer, Jennifer J Pointon, et al.
Pageof 8